Προωθημένο
U.S. Software as a Medical Device Market: Key Players & Industry Outlook
The U.S. Software as a Medical Device (SaMD) market was valued at USD 2.1 billion in 2023 and is projected to reach USD 8.4 billion by 2032, growing at a CAGR of 16.5% (2024–2032). The growth is driven by the rise in AI- and ML-powered healthcare applications, increasing adoption of digital therapeutics (DTx), and a strong regulatory framework from the U.S. FDA supporting innovation in...
0 Σχόλια 0 Μοιράστηκε 104 Views 0 Προεπισκόπηση
Προωθημένο
Προωθημένο
Προωθημένο